New injection tested to stop dangerous sugar crashes after bariatric surgery
NCT ID NCT05928390
Summary
This study is testing if an injectable medication called pasireotide can help control severe low blood sugar episodes that sometimes occur after weight-loss surgery. About 93 adults who experience these episodes despite dietary changes will test one of three doses or a placebo for 12 weeks, followed by a longer treatment period. The main goal is to see if the medication safely reduces the frequency and severity of these dangerous sugar drops.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST BARIATRIC HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP Hopital Europeen Georges Pompidou, 20, rue Leblanc,
Paris, 75015, France
-
Azienda Ospedale - Università Padova, Clinica Medica 3, Via Giustiniani, 2,
Padua, 35128, Italy
-
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Palermo, Italy
-
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, L.go Gemelli 8
Rome, Italy
-
Guy's Hospital
London, United Kingdom
-
HCL Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Hammersmith Hospital
London, W12 OHS, United Kingdom
-
Hopital Rangueil, Attachée de Recherche Clinique, Centre Investigation Clinique, CHU, Cedex 9, France
Toulouse, 31059, France
-
Hospital Clinic Barcelona, Lipid Clinic End, Nutr. Service Hospital Clinic, C. Villarroel, 170,
Barcelona, 08036, Spain
-
Hospital Clinico San Carlos, C/ Prof Martin Lagos s/n, Spain
Madrid, 28040, Spain
-
Hospital Germans Trias i Pujol
Barcelona, 08916, Spain
-
Hospital Universitari de Girona Dr. Josep Trueta
Girona, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Reina Sofia
Córdoba, 14004, Spain
-
Hospital Universitario Vall d'Hebron, Passeig Vall d´Hebron 119-129, Spain
Barcelona, 08035, Spain
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola
Bologna, 40138, Italy
-
Joslin Diabetes CenterJoslin Diabetes Center, One Joslin Place
Boston, Massachusetts, 02215, United States
-
King's College Hospital NHS Foundation Trust, Denmark Hill, SE5 9RS
London, EC1A 1AA, United Kingdom
-
Mayo Clinic - Rochester, 200 First Street, SW, 55905
Rochester, Minnesota, 55905, United States
-
Montefiore Medical Center, 111 E 210th Street,
The Bronx, New York, 10467, United States
-
NOLA Care
Metairie, Louisiana, 70006, United States
-
North Bristol NHS Trust
Bristol, BS10 5NB, United Kingdom
-
Northwestern University - Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60628, United States
-
Stanford University School of Medicine, Endocrinology, 800 Welch Road,
Palo Alto, California, 94305, United States
-
Universitaire Ziekenhuizen Leuven, Department of Gastroenterology and Hepatology,Herestraat 49
Leuven, 3000, Belgium
-
University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr,
San Antonio, Texas, 78229, United States
-
University of Wisconsin Health W. E. Clinic END, 451 Junction Rd,
Madison, Wisconsin, 53717, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37204, United States
-
Velocity Clinical Research - Annapolis
Annapolis, Maryland, 21401, United States
Conditions
Explore the condition pages connected to this study.